JP2000501711A - 疼痛を処置する方法 - Google Patents

疼痛を処置する方法

Info

Publication number
JP2000501711A
JP2000501711A JP09521436A JP52143697A JP2000501711A JP 2000501711 A JP2000501711 A JP 2000501711A JP 09521436 A JP09521436 A JP 09521436A JP 52143697 A JP52143697 A JP 52143697A JP 2000501711 A JP2000501711 A JP 2000501711A
Authority
JP
Japan
Prior art keywords
thiadiazoli
tetrahydro
methylpyridine
branched
octane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP09521436A
Other languages
English (en)
Japanese (ja)
Inventor
ミッチ，チャールズ・エイチ
シャノン，ハーラン・イー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of JP2000501711A publication Critical patent/JP2000501711A/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Processing Of Meat And Fish (AREA)
JP09521436A 1995-12-07 1996-12-05 疼痛を処置する方法 Pending JP2000501711A (ja)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US831895P 1995-12-07 1995-12-07
US831295P 1995-12-07 1995-12-07
US831395P 1995-12-07 1995-12-07
US829595P 1995-12-07 1995-12-07
US830695P 1995-12-07 1995-12-07
US831995P 1995-12-07 1995-12-07
US829895P 1995-12-07 1995-12-07
US60/008,298 1995-12-07
US60/008,318 1995-12-07
US60/008,312 1995-12-07
US60/008,313 1995-12-07
US60/008,319 1995-12-07
US60/008,306 1995-12-07
US60/008,295 1995-12-07
PCT/US1996/019390 WO1997020556A1 (fr) 1995-12-07 1996-12-05 Methode de traitement de la douleur

Publications (1)

Publication Number Publication Date
JP2000501711A true JP2000501711A (ja) 2000-02-15

Family

ID=27567403

Family Applications (1)

Application Number Title Priority Date Filing Date
JP09521436A Pending JP2000501711A (ja) 1995-12-07 1996-12-05 疼痛を処置する方法

Country Status (14)

Country Link
EP (1) EP0866702A4 (fr)
JP (1) JP2000501711A (fr)
KR (1) KR19990071977A (fr)
CN (1) CN1208348A (fr)
AU (1) AU715645B2 (fr)
CA (1) CA2239732A1 (fr)
CZ (1) CZ174598A3 (fr)
EA (1) EA199800535A1 (fr)
HU (1) HUP0000110A3 (fr)
IL (1) IL124786A0 (fr)
NO (1) NO982582L (fr)
NZ (1) NZ324594A (fr)
PL (1) PL327144A1 (fr)
WO (1) WO1997020556A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE248166T1 (de) 1999-06-04 2003-09-15 Lilly Co Eli 7-oxo-2-azabicyclo(2.2.1)heptane als selektive muskarin-rezeptor antagonisten
CA3042642A1 (fr) 2013-08-12 2015-02-19 Pharmaceutical Manufacturing Research Services, Inc. Comprime extrude anti-abus a liberation immediate
US9492444B2 (en) 2013-12-17 2016-11-15 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
US10172797B2 (en) 2013-12-17 2019-01-08 Pharmaceutical Manufacturing Research Services, Inc. Extruded extended release abuse deterrent pill
CA2955229C (fr) 2014-07-17 2020-03-10 Pharmaceutical Manufacturing Research Services, Inc. Forme posologique remplie de liquide anti-abus a liberation immediate
AU2015336065A1 (en) 2014-10-20 2017-05-04 Pharmaceutical Manufacturing Research Services, Inc. Extended release abuse deterrent liquid fill dosage form
JP2022523355A (ja) * 2019-02-22 2022-04-22 カルナ セラピューティックス，インコーポレイテッド 神経障害の処置のための重水素化キサノメリンの化合物及び方法
US11534434B2 (en) 2019-11-15 2022-12-27 Karuna Therapeutics, Inc. Xanomeline derivatives and methods for treating neurological disorders
CN115974863B (zh) * 2021-10-14 2024-12-31 南京迈诺威医药科技有限公司 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
WO1993014089A1 (fr) * 1992-01-13 1993-07-22 Novo Nordisk A/S Composes heterocycliques, leur preparation et leur utilisation
US5605701A (en) * 1995-02-17 1997-02-25 Eli Lilly And Company Transdermal formulation

Also Published As

Publication number Publication date
CZ174598A3 (cs) 1999-01-13
CN1208348A (zh) 1999-02-17
HUP0000110A2 (hu) 2000-06-28
EP0866702A1 (fr) 1998-09-30
EP0866702A4 (fr) 2001-07-25
PL327144A1 (en) 1998-11-23
NO982582D0 (no) 1998-06-05
NO982582L (no) 1998-08-03
KR19990071977A (ko) 1999-09-27
IL124786A0 (en) 1999-01-26
AU715645B2 (en) 2000-02-10
WO1997020556A1 (fr) 1997-06-12
EA199800535A1 (ru) 1998-12-24
HUP0000110A3 (en) 2000-09-28
AU1147697A (en) 1997-06-27
NZ324594A (en) 1999-09-29
CA2239732A1 (fr) 1997-06-12

Similar Documents

Publication Publication Date Title
AU2006234627C1 (en) Therapeutic agent for dyskinesia
JP2000507945A (ja) 痛みを処置する方法
JPH10508029A (ja) 不安を治療する方法
CA2630072A1 (fr) Compositions pharmaceutiques
TW200815008A (en) Method for enhancing cognitive function
BG63190B1 (bg) Използване на оптически чист (+) норцисаприд за лечение на емезис и смущения на централната нервна система
JP4867123B2 (ja) 神経因性疼痛治療剤および神経因性疼痛のモデル動物
JPH10508028A (ja) 不安を治療する方法
JP2000501711A (ja) 疼痛を処置する方法
US20070281924A1 (en) MIF inhibitors for treating neuropathic pain and associated syndromes
WO1997020556A9 (fr) Methode de traitement de la douleur
JP2000501709A (ja) 疼痛治療用組成物
CN100354274C (zh) 神经变性疾病的预防和治疗药物
EP1007041A1 (fr) Composition analgesique
RU2419433C2 (ru) Средство для профилактики или лечения алкогольной зависимости и зависимости от лекарственных веществ
WO1998046601A1 (fr) Composition pour le traitement de la douleur
EP0709093A2 (fr) Utilisation d'une oxadiazole ou thiadiazole azabicyclique dans le traitement de l'anxiété
US20090270400A1 (en) Painkilling association comprising a dihydroimidazopyrazine derivative
US6090829A (en) Method for treating excessive aggression
MXPA98004525A (en) Method for treating do
EP0821958A2 (fr) Utilisation de la 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tétrahydro-1-méthylpyridine (xanoméline) pour traiter l'agressivité excessive
MXPA98004519A (en) Composition to treat do
JPWO2018159716A1 (ja) アルコール使用障害の治療薬
HK1008931A (en) Use of 3-(4-hexyloxy-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine (xanomeline ) for treating excessive aggression
HK1107943A (en) Agent for treating involuntary movement